COMMUNIQUÉS West-GlobeNewswire

OPKO Provides Update on the Development of OPK-88004, a Selective Androgen Receptor Modulator
01/02/2019
MIAMI, Jan. 31, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced an update on the ongoing development plans of OPK-88004, a selective androgen receptor modulator (SARM). OPK-88004 has the ability [...]
Future Non-Coverage Determination for 4Kscore Test Posted by Novitas
01/02/2019
MIAMI, Jan. 31, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that Novitas Solutions, Inc. has issued a notice of a future non-coverage determination for the 4Kscore test® to be effective [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/02/2019
CAMBRIDGE, Mass., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on January 31, 2019, that were previously [...]
Resverlogix Closes $6.6 Million Private Placement with Shenzhen Hepalink
01/02/2019
CALGARY, Alberta, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today it has closed a private placement of approximately 2.2 million equity units to Shenzhen [...]
Nuvectra® Appoints Dr. Fred B. Parks as Chief Executive Officer
31/01/2019
Elects Christopher G. Chavez as a Member of the Board of Directors PLANO, Texas, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the [...]
Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2018
31/01/2019
OTTAWA, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) reported its audited financial results for the year ended October 31, 2018. Unless otherwise noted, all figures are in Canadian currency. [...]
resTORbio to Host Key Opinion Leader Symposium on TORC1 Inhibition and Neurodegenerative Disease
31/01/2019
BOSTON, Jan. 31, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company developing a new class of medicines that target the biology of aging to prevent or treat age-related [...]
Milestone Scientific Announces Proposed Public Offering of Common Stock and Warrants
31/01/2019
LIVINGSTON, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today that it [...]
Geron Announces Expansion of Leadership Team with Appointment of Chief Medical Officer
31/01/2019
Aleksandra Rizo, M.D., Ph.D., former clinical lead for the imetelstat program at Janssen, joins Geron as Chief Medical Officer Additional office to be opened in New Jersey to support expansion of clinical development [...]
The Cooper Companies Announces Release Date for First Quarter 2019
31/01/2019
PLEASANTON, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced it will release first quarter 2019 financial results on Tuesday, March 5, 2019, at 4:15 PM ET. Following the [...]
LHC Group and Unity Health Announce Joint Venture Agreement in Arkansas
31/01/2019
LAFAYETTE, La., Jan. 31, 2019 (GLOBE NEWSWIRE) -- LHC Group (NASDAQ: LHCG) and Unity Health today announced finalization of an equity partnership agreement to purchase and share ownership of two home health providers in [...]
Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Blue Cross Blue Shield of North Carolina
31/01/2019
MINNEAPOLIS, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
31/01/2019
Oasmia Pharmaceutical AB (publ) (”Oasmia” or ”Company” or “Group”) on 18 April 2018 issued a convertible loan with a total nominal amount of MSEK 26. In total circa MSEK 7 of the convertible loan has during January 2019 [...]
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2018 Preliminary Selected Financial Results; Provides 2019 Revenue Guidance
31/01/2019
2018 revenue of $251.2 million, an increase of 58 percent from 2017 Fourth quarter revenue of $66.8 million, an increase of 25 percent from fourth quarter 2017 Repurchase in the fourth quarter of 1.1 million shares of [...]
Integra LifeSciences to Host Fourth Quarter and Full-Year 2018 Earnings Results Conference Call on February 21, 2019
31/01/2019
PLAINSBORO, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full-year 2018 financial results [...]
Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock
31/01/2019
RUTHERFORD, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]
The NFL Alumni Leads the Way in Brain Health Awareness Through Participation in The Living Brain Project
31/01/2019
Brookfield, WI, Jan. 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, through their Brain Armor® subsidiary, is pleased to announce that the NFL [...]
ICC Partnership Brings Innovative Solutions to EU Medical Market -- CFN Media
31/01/2019
SEATTLE, Jan. 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Neovacs announces its clinical advisory board meeting to design the Phase III Study for IFNalpha Kinoide in lupus - Paris February 11th
31/01/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES ITS CLINICAL ADVISORY BOARD MEETING TO DESIGN THE PHASE III STUDY FOR IFN-K IN LUPUS MEETING TO BE HELD IN PARIS, FEBRUARY 11 TH Paris and Boston, January [...]

Pages